Roc - OmicsDI

Show results for

Unknown (24027)
Genomics (351)
Proteomics (192)
Transcriptomics (185)
Metabolomics (77)
Clinical (26)
Other (9)
Methylation profiling (7)
Models (5)

Organisms

Homo sapiens (292)
Aerococcus urinae NBRC 15544 = CCUG 36881 (117)
Andropogon gerardi (117)
Bacteria (117)
Bartonella quintana JK 31 (117)
Canis lupus familiaris (117)
Cnidaria (117)
Ectopseudomonas oleovorans CECT 5344 (117)
Ensifer adhaerens (117)
Globicatella sanguinis (117)
Halictus scabiosae (117)
Human immunodeficiency virus 1 (117)
Mesocricetus auratus (117)
Methylohalobius crimeensis 10Ki (117)
Miscanthus x giganteus (117)
Mus musculus (117)
Mus musculus (25)
Rattus norvegicus (6)
synthetic construct (4)
Saccharomyces cerevisiae (3)
Arabidopsis thaliana (3)
Helicobacter pylori (2)
Burkholderia cenocepacia (1)
bacterium (1)
Collimonas arenae (1)
Neisseria meningitidis (1)
Bacillus subtilis (1)
Trachemys scripta (1)
human feces metagenome (1)
Oryctolagus cuniculus (1)

Organisms

Homo sapiens (184)
Mus musculus (13)
human gut metagenome (3)
Rattus norvegicus (2)
Streptococcus pyogenes A20 (1)
Trachemys scripta (1)
Saccharum hybrid cultivar (1)
Human immunodeficiency virus 1 (1)
Oryza sativa Indica Group (1)
human feces metagenome (1)
feces metagenome (1)
Mycobacterium tuberculosis (1)
Saccharomyces cerevisiae (1)
unidentified (1)

Repository

ENA (281)
geo (162)
pride (117)
biostudies-arrayexpress (109)
MetaboLights (76)
iProX (53)
MassIVE (15)
jPOST (6)
BioModels (5)
EVA (1)
GNPS (1)

Tissue

Blood serum (26)
Blood plasma (24)
Blood cell (12)
Brain (10)
Blood (9)
Urine (7)
Cell culture (4)
Epithelial cell (4)
Saliva (4)
Blood platelet (3)
Cerebrospinal fluid (3)
Kidney (3)
Ovary (2)
Platelet (2)
Bile (1)
Bladder cell (1)
Breast cancer cell (1)
Cell suspension culture (1)
Cerebrospinal fluid secreting cell (1)
Colon (1)
Ectocervical epithelium (1)
Endocervical epithelium (1)
Extracellular vesicle (1)
Feces (1)
Glioblastoma cell (1)
Left ovary (1)
Liver (1)
Lung (1)
Lymph node (1)
Nasopharynx (1)

Disease

Colon cancer (8)
Alzheimer's disease (7)
Colorectal cancer (5)
Parkinson's disease (5)
Colorectal cancer (4)
Breast cancer (4)
Colorectal Cancer (3)
Colorectal Neoplasms (3)
COVID-19 (3)
Cardiovascular system disease (3)
Malignant neoplasm of ovary (3)
Non-small cell lung carcinoma (3)
Diabetic retinopathy (2)
Glioblastoma (2)
Rheumatoid arthritis (2)
Stomach carcinoma (2)
Gestational diabetes mellitus (1)
Disease controled patient (1)
Disease controled patient (1)
Advanced colorectal neoplasia (1)
Colorectal Adenoma (1)
Gastrointestinal cancer (1)
Esopahgeal cancer, Gastric cancer, Colorectal cancer, Pancreatic cancer, Breast Cancer (1)
Colorectal adenoma (1)
Colorectal neoplasia (1)
Colorectal adenoma (1)
Upper Gastro-Intestinal Cancer (1)
Colorectal tumor (1)
Gastrointestinal Neoplasms (1)
Neoplasms (1)

Technology Type

Mass Spectrometry (117)
Mass spectrometry (53)
Shotgun proteomics (46)
Bottom-up proteomics (20)
SRM/MRM (16)
Mass spectrometry assay (14)
Data-independent acquisition (12)
SWATH MS (10)
Gel-based experiment (9)
NMR spectroscopy (8)
Data-dependent acquisition (8)
All-ion fragmentation (7)
Top-down proteomics (6)
Affinity purification coupled with mass spectrometry proteomics (4)
DiaPASEF (4)
MSE (4)
Affinity proteomics (3)
HDMSE (3)
Mass spectrometry imaging (3)
Olink affinity proteomics (3)
NMR spectroscopy assay (2)
Chemical cross-linking coupled with mass spectrometry proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (27)
Liquid Chromatography MS - negative - reverse phase (20)
Liquid Chromatography MS - positive - hilic (10)
Liquid Chromatography MS - negative - hilic (9)
NextSeq 500 (6)
Q Exactive (6)
Bruker (5)
Liquid Chromatography MS - positive - reverse-phase (5)
Liquid Chromatography MS - negative - reverse-phase (5)
Nuclear Magnetic Resonance (NMR) - (4)
Orbitrap Fusion Lumos (3)
Gas Chromatography MS - positive (3)
TripleTOF 5600 (2)
Direct infusion MS - negative (2)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (2)
Gas Chromatography MS - Positive (GC-MS (Positive)) (2)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (2)
Direct infusion MS - positive (2)
Liquid Chromatography MS - alternating - reverse-phase (2)
Illumina HiSeq 2000 platform (1)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 4000 (1)
- (1)
Agilent 6495C Triple Quadrupole (1)
Orbitrap Eclipse (1)
Orbitrap Exploris 480 (1)
Q Exactive HF (1)
Synapt MS (1)
TripleTOF 6600 (1)

Publication Date

2025 (80)
2022 (58)
2024 (55)
2026 (50)
2023 (42)
2021 (37)
2013 (29)
2020 (25)
2019 (21)
2018 (19)
2016 (19)
2011 (19)
2017 (17)
2010 (14)
2014 (13)
2012 (13)
2015 (10)
2009 (10)
2008 (10)
2007 (2)
2005 (1)

CHEBI ID

CHEBI:15428 (17)
CHEBI:16737 (17)
CHEBI:28044 (16)
CHEBI:16919 (15)
CHEBI:30769 (14)
CHEBI:25094 (13)
CHEBI:25017 (13)
CHEBI:15891 (13)
CHEBI:16449 (13)
CHEBI:15354 (13)
CHEBI:17895 (13)
CHEBI:18186 (12)
CHEBI:27266 (12)
CHEBI:27897 (12)
CHEBI:17295 (12)
CHEBI:26271 (11)
CHEBI:18237 (11)
CHEBI:16870 (11)
CHEBI:17750 (11)
CHEBI:16643 (11)
CHEBI:27570 (10)
CHEBI:28300 (10)
CHEBI:17268 (10)
CHEBI:16467 (10)
CHEBI:17203 (10)
CHEBI:15971 (10)
CHEBI:29016 (10)
CHEBI:16414 (10)
CHEBI:15603 (10)
CHEBI:17368 (10)

Metabolite Name

Creatinine (13)
L-Tyrosine (12)
Uric acid (11)
Xanthine (11)
Creatine (11)
Betaine (10)
L-Histidine (10)
Taurine (10)
Uridine (10)
Hypoxanthine (10)
Glycine (9)
L-Methionine (9)
Leucine (8)
L-Proline (8)
L-Arginine (8)
L-Threonine (8)
Choline (8)
Alanine (8)
Phenylalanine (8)
D-Mannose (8)
L-Valine (8)
L-Phenylalanine (8)
Inosine (8)
Histidine (7)
Uracil (7)
Valine (7)
Ornithine (7)
Deoxycholic acid (7)
Lysine (7)
Asparagine (7)

First Public Date

2025 (66)
2026 (39)
2014 (28)
2024 (26)
2021 (22)
2022 (21)
2023 (18)
2020 (16)
2018 (14)
2016 (10)
2017 (8)
2019 (6)
2013 (5)
2015 (2)

Modelling Approach

Computational model (4)
Machine learning (1)

Study status

Not yet recruiting (11)
Recruiting (11)
Not provided (2)
Completed (2)

Lab affiliation

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics & Cognitive Research, Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands (5)
Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, N0. 1037 Luoyudong Road, Hongshan District, Wuhan 430074 (3)
Functional proteomics group; Molecular Biomedicine department; CIB-CSIC (3)
Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark (2)
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center (2)
Instituto de Investigaciones Sanitarias de Santiago de Compostela (2)
Prof. Dr. M. Waheed Akhtar, School of Biological Sciences, University of the Punjab, Lahore, Pakistan (2)
School of Nursing and School of Medicine, Department of Neurology, Johns Hopkins University, Baltimore, MD, United States (2)
1. Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates. 2. College of Pharmacy, Department of Medicinal Chemistry, University of Sharjah, 27272, United Arab Emirates (1)
1Dept. of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205 2Dept. of Environmental and Occupational Health, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205 (1)
1Platelet Proteomics Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade Santiago de Compostela; and Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. (1)
Associate Professor of Neurology Institute for Cell Engineering Johns Hopkins University School of Medicine (1)
Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005 Hradec Kralove, Czech Republic (1)
CAS Center for Excellence in Molecular Plant Sciences (1)
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chines Academy of Sciences, Beijing, China. (1)
CHU Angers, Angers, France Inserm UMR 1307, CNRS UMR 6075, Université de Nantes, CRCI2NA, Université d'Angers, Angers, France (1)
Capital Normal University (1)
Chair, Dept of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada (1)
Chief Scientific Officer, Sangui Bio (1)
Chinese Academy of Sciences Shanghai Institute of Materia Medica (1)
College of chemistry and molecular engineering, Peking University (1)
College of chemistry and molecular engineering, Peking University. (1)
Department of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, Republic of KOREA (1)
Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, N0. 1037 Luoyudong Road, Hongshan District, Wuhan 430074, China. (1)
Department of Biomedicine, Aarhus University, Denmark (1)
Department of Biophysics All India Institute of Medical Sciences New Delhi 110029 India (1)
Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India (1)
Department of Cardiology, the Third Hospital of Jilin University, Changchun 130033, China (1)
Department of Chemistry, SUSTech (1)
Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Keyword

RISK FACTOR (1)
Biomaker (1)
Stool (1)
Simvastatin (1)
SCREENING (1)
NRS 2002 (1)
Postoperative survival (1)
Nomogram (1)
Multicenter study (1)

IsPrivate

False (5)

Submitter Keywords

Machine Learning Model (5)
Ersilia (4)
FAIR-AIML (3)

Classification

bacteria (2)
viruses (1)

Modification

N6 (2)
N6-dimethyl-L-lysine (2)

Study type

Transcription profiling by array (69)
Other (20)
ChIP-seq (8)
Methylation profiling by array (5)
Observational (5)
RNA-seq of coding RNA (4)
Comparative genomic hybridization by array (3)
MicroRNA profiling by array (3)
Baseline (2)
Transcription profiling by RT-PCR (2)
Other (2)
RNA-seq of non coding RNA (2)
Transcription profiling by SAGE (1)
ChIP-chip by tiling array (1)
One-color microarray (1)
Human - Single-cell sequencing (1)
Genotyping by array (1)
DNA-seq (1)
Proteomic profiling by array (1)
Genotyping by high throughput sequencing (1)
RNA-seq of coding RNA from single cells (1)
Interventional (1)

Release Date

2025 (4620)
2022 (3926)
2023 (3333)
2024 (3097)
2021 (2795)
2020 (1694)
2019 (989)
2018 (725)
2017 (597)
2026 (490)
2016 (489)
2015 (367)
2014 (290)
2013 (198)
2012 (144)
2011 (127)
2010 (97)
2009 (53)
2008 (42)
2007 (24)
2006 (18)
2005 (9)
2002 (5)
2004 (4)
2003 (2)
1997 (1)

Location

China (23)
United Kingdom (1)
Japan (1)

Previous page
1 / 2488
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 2488
Next page

Sort by:

Relevance

Page size

Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry (Cardiac Epistry) Version 3 (ROC-Cardiac Epistry 3-BioLINCC)

PRJNA1143087 | ENA

Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry (Cardiac Epistry) Version 3 (ROC-Cardiac Epistry 3-BioLINCC)

PRJNA1143086 | ENA

Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry (Cardiac Epistry) Version 1 and 2 (ROC-Cardiac Epistry 1 and 2-BioLINCC)

PRJNA1169110 | ENA

Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry (Cardiac Epistry) Version 1 and 2 (ROC-Cardiac Epistry 1 and 2-BioLINCC)

PRJNA1169112 | ENA

Disruption of autophagic degradation with ROC-325 antagonizes renal cell carcinoma pathogenesis

Autophagy plays important roles in malignant pathogenesis and drug resistance. We used medicinal chemistry approaches to generate a series of novel agents that inhibit autophagic degradation. ROC-325 was selected as a lead compound for further evaluation. Comprehensive in vitro and in vivo studies w...

ORGANISM(S): Homo sapiens

2018-02-16 | GSE89766 | GEO

Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation on Helicopter Study (PROHS)(ROC-PROHS-BioLINCC)

PRJNA1181038 | ENA

Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation on Helicopter Study (PROHS)(ROC-PROHS-BioLINCC)

PRJNA1181039 | ENA

Resuscitation Outcomes Consortium (ROC) Pragmatic Randomized Optimal Platelet and Plasma Ratios (ROC-PROPPR-BioLINCC)

PRJNA1460411 | ENA

Resuscitation Outcomes Consortium (ROC) Pragmatic Randomized Optimal Platelet and Plasma Ratios (ROC-PROPPR-BioLINCC)

PRJNA1460410 | ENA

Rocaglamide selectively inhibits the G1-S-phase transition in cancer cells by activation of the ATM/ATR-mediated Chk1/2 cell cycle checkpoints

The cell division cycle is tightly controlled in normal cells. Cancer cells are characterized by deregulation in cell division cycle, which is associated with increased DNA replication and elevated cellular proliferation. Recently, genetic studies indicate that cyclin dependent kinases CDK2, CDK4 an...

ORGANISM(S): Homo sapiens

2013-10-12 | E-GEOD-41072 | biostudies-arrayexpress

Previous page
1 / 2488
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 2488
Next page

Sort by:

Relevance

Page size

24879 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Study status

Lab affiliation

Tags

Keyword

IsPrivate

Submitter Keywords

Classification

Modification

Study type

Release Date

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets